AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
BioCardia has elected Marvin Slosman to its Board of Directors, effective December 2, 2025. He brings expertise in interventional cardiology and a track record in advancing breakthrough technologies. Dr. Richard Krasno has completed his term and departed the Board. Slosman's experience will be valuable as BioCardia continues to scale its portfolio and deliver innovative solutions.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet